1. Home
  2. CYPH vs KNDI Comparison

CYPH vs KNDI Comparison

Compare CYPH & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cypherpunk Technologies Inc.

CYPH

Cypherpunk Technologies Inc.

HOLD

Current Price

$2.43

Market Cap

73.3M

Sector

Health Care

ML Signal

HOLD

Logo Kandi Technologies Group Inc

KNDI

Kandi Technologies Group Inc

HOLD

Current Price

$0.61

Market Cap

61.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYPH
KNDI
Founded
2011
2002
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
73.3M
61.9M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
CYPH
KNDI
Price
$2.43
$0.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.7M
69.8K
Earning Date
05-13-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
103.87
N/A
EPS
N/A
N/A
Revenue
$1,500,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$0.56
52 Week High
$3.70
$1.40

Technical Indicators

Market Signals
Indicator
CYPH
KNDI
Relative Strength Index (RSI) 80.38 38.27
Support Level $0.69 $0.57
Resistance Level N/A $0.70
Average True Range (ATR) 0.34 0.04
MACD 0.11 -0.00
Stochastic Oscillator 69.43 30.66

Price Performance

Historical Comparison
CYPH
KNDI

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.

Share on Social Networks: